Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Department of Neurosurgery, University at Buffalo, Buffalo, NY, United States.
Clin Neurol Neurosurg. 2024 Oct;245:108497. doi: 10.1016/j.clineuro.2024.108497. Epub 2024 Aug 5.
Brain metastases (BM) are the most common adult intracranial tumors, representing a significant source of morbidity in patients with systemic malignancy. Frailty indices, including 11- and 5-factor modified frailty indices (mFI-11 and mFI-5), American Society of Anesthesiologists (ASA) physical status classification, and Charlson Comorbidity Index (CCI), have recently demonstrated an important role in predicting high-value care outcomes in neurosurgery. This study aims to investigate the efficacy of the newly developed Hospital Frailty Risk Score (HFRS) on postoperative outcomes in BM patients.
Adult patients with BM treated surgically at a single institution were identified (2017-2019). HFRS was calculated using ICD-10 codes, and patients were subsequently separated into low (<5), intermediate (5-15), and high (>15) HFRS cohorts. Multivariate logistic regressions were utilized to identify associations between HFRS and complications, length of stay (LOS), hospital charges, and discharge disposition. Model discrimination was assessed using receiver operating characteristic (ROC) curves.
A total of 356 patients (mean age: 61.81±11.63 years; 50.6 % female) were included. The mean±SD for HFRS, mFI-11, mFI-5, ASA, and CCI were 6.46±5.73, 1.31±1.24, 0.95±0.86, 2.94±0.48, and 8.69±2.07, respectively. On multivariate analysis, higher HFRS was significantly associated with greater complication rate (OR=1.10, p<0.001), extended LOS (OR=1.13, p<0.001), high hospital charges (OR=1.14, p<0.001), and nonroutine discharge disposition (OR=1.12, p<0.001), and comparing the ROC curves of mFI-11, mFI-5, ASA,and CCI, the predictive accuracy of HFRS was the most superior for all four outcomes assessed.
The predictive ability of HFRS on BM resection outcomes may be superior than other frailty indices, offering a new avenue for routine preoperative frailty assessment and for managing postoperative expectations.
脑转移瘤(BM)是最常见的成人颅内肿瘤,是系统性恶性肿瘤患者发病率的重要来源。衰弱指数,包括 11 项和 5 项修正衰弱指数(mFI-11 和 mFI-5)、美国麻醉医师协会(ASA)身体状况分类和 Charlson 合并症指数(CCI),最近在预测神经外科高价值治疗结果方面发挥了重要作用。本研究旨在探讨新开发的医院衰弱风险评分(HFRS)在 BM 患者术后结果中的疗效。
在单机构治疗的 BM 成年患者中确定了 HFRS(2017-2019 年)。HFRS 使用 ICD-10 代码计算,随后将患者分为低(<5)、中(5-15)和高(>15)HFRS 队列。使用多变量逻辑回归确定 HFRS 与并发症、住院时间(LOS)、住院费用和出院处置之间的关联。使用接收者操作特征(ROC)曲线评估模型区分度。
共纳入 356 例患者(平均年龄:61.81±11.63 岁;50.6%女性)。HFRS、mFI-11、mFI-5、ASA 和 CCI 的平均值±标准差分别为 6.46±5.73、1.31±1.24、0.95±0.86、2.94±0.48 和 8.69±2.07。多变量分析显示,较高的 HFRS 与更高的并发症发生率(OR=1.10,p<0.001)、更长的 LOS(OR=1.13,p<0.001)、更高的住院费用(OR=1.14,p<0.001)和非常规出院处置(OR=1.12,p<0.001)显著相关,比较 mFI-11、mFI-5、ASA 和 CCI 的 ROC 曲线,HFRS 在评估的所有四项结果中的预测准确性均最高。
HFRS 对 BM 切除术结果的预测能力可能优于其他衰弱指数,为常规术前衰弱评估和管理术后预期提供了新途径。